MIMOSAPHARMA
ActiveSummary
MIMOSAPHARMA has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €29,738 and a net result of €24,738. Its solvency ranks better than 95% of 12,661 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
Articles of association
What the company does
- Name clauseThe name the company operates under according to its articles.
- MIMOSAPHARMA
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Région de Bruxelles-Capitale” (deed in French)
Who represents it, and how
- Who signsWho may bind the company towards others, for example by signing a contract.
- “Article 13. Pouvoir de représentation Chaque administrateur représente la société à l'égard des tiers et en justice, soit en demandant, soit…”
- Board ruleHow the board is made up, meets and takes decisions.
- “Un ou plusieurs, administrateur(s)” (deed in French)“Moitié au moins présents ou représentés, majorité des voix” (deed in French)
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- “Article 17. Tenue et convocation Il est tenu chaque année, au siège, une assemblée générale ordinaire le troisième vendredi du mois de juin…” (deed in French)